Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure

Journal of Endocrinology

Volumn 206, Issue 1, 2010, Pages 121-130

  Scarlett, Jarrad M ^a   Bowe, Darren D ^a   Zhu, Xinxia ^a   Batra, Ayesha K ^a   Grant, Wilmon F ^a   Marks, Daniel L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOCORTIN; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN RECEPTOR; PROTEIN AGRP; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CARDIAC CACHEXIA; CONTROLLED STUDY; HEART FAILURE; HEART LEFT VENTRICLE OVERLOAD; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

AGOUTI-RELATED PROTEIN; ANIMALS; AORTA; BASAL METABOLISM; BODY COMPOSITION; CACHEXIA; CHRONIC DISEASE; CONSTRICTION; CORONARY VESSELS; HEART DISEASES; HEART FAILURE; INJECTIONS, INTRAVENTRICULAR; LIGATION; MALE; MELANOCORTINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; RECEPTOR, MELANOCORTIN, TYPE 4; SIGNAL TRANSDUCTION;

EID: 77953845379     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-09-0397     Document Type: Article

References (45)

1. Anker SD & Sharma R 2002 The syndrome of cardiac cachexia. International Journal of Cardiology 85 51-66.
2. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA & Coats AJ 1997 Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 1050-1053.
3. Anker SD, Ponikowski PP, Clark AL, Leyva F, Rauchhaus M, Kemp M, Teixeira MM, Hellewell PG, Hooper J, Poole-Wilson PA et al. 1999 Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. European Heart Journal 20 683-693.
4. Anker S, Steinborn W & Strassburg S 2004 Cardiac cachexia. Annals of Medicine 36 518-529.
5. Baskin DG, Hahn TM & Schwartz MW 1999 Leptin sensitive neurons in the hypothalamus. Hormone and Metabolic Research 31 345-350.
6. Campbell IL 1998 Transgenic mice and cytokine actions in the brain: bridging the gap between structural and functional neuropathology. Brain Research. Brain Research Reviews 26 327-336.
7. Cheung W, Yu PX, Little BM, Cone RD, Marks DL & Mak RH 2005 Role of leptin and melanocortin signaling in uremia-associated cachexia. Journal of Clinical Investigation 115 1659-1665.
8. Cone RD 2005 Anatomy and regulation of the central melanocortin system. Nature Neuroscience 8 571-578.
9. Cone RD, Cowley MA, Butler AA, Fan W, Marks DL & Low MJ 2001 The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. International Journal of Obesity and Related Metabolic Disorders 25 (Suppl 5) S63-S67.
10. Cowie MR,Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V & Sutton GC 1999 Incidence and aetiology of heart failure: a populationbased study. European Heart Journal 20 421-428.
11. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML et al. 2003 The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37 649-661.
12. Curtis JP, Selter JG,Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F et al. 2005 The obesity paradox: body mass index and outcomes in patients with heart failure. Archives of Internal Medicine 165 55-61.
13. Dutka DP, Elborn JS, Delamere F, Shale DJ & Morris GK 1993 Tumour necrosis factor alpha in severe congestive cardiac failure. British Heart Journal 70 141-143. (Pubitemid 23248028)
14. Fan W, Boston BA, Kesterson RA, Hruby VJ & Cone RD 1997 Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385 165-168. (Pubitemid 27034218) (Pubitemid 27034218)
15. Foster AC, Joppa M, Markison S, Gogas KR, Fleck BA, Murphy BJ,WolffM, Cismowski MJ, Ling N, Goodfellow VS et al. 2003 Body weight regulation by selective MC4 receptor agonists and antagonists. Annals of the New York Academy of Sciences 994 103-110.
16. Francis J, Chu Y, Johnson AK, Weiss RM & Felder RB 2004 Acute myocardial infarction induces hypothalamic cytokine synthesis. American Journal of Physiology. Heart and Circulatory Physiology 286 H2264-H2271.
17. Getting SJ, Di Filippo C, Christian HC, Lam CW, Rossi F, D'Amico M & Perretti M 2004 MC-3 receptor and the inflammatory mechanisms activated in acute myocardial infarct. Journal of Leukocyte Biology 76 845-853.
18. Gould KE, Taffet GE, Michael LH, Christie RM, Konkol DL, Pocius JS, Zachariah JP, Chaupin DF, Daniel SL, Sandusky GE Jr et al. 2002 Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure. American Journal of Physiology. Heart and Circulatory Physiology 282 H615-H621.
19. Helies-Toussaint C, Moinard C, Rasmusen C, Tabbi-Anneni I, Cynober L & Grynberg A 2005 Aortic banding in rat as a model to investigate malnutrition associated with heart failure. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 288 R1325-R1331.
20. Joppa MA, Ling N, Chen C, Gogas KR, Foster AC & Markison S 2005 Central administration of peptide and small molecule MC4 receptor antagonists induce hyperphagia in mice and attenuate cytokine-induced anorexia. Peptides 26 2294-2301.
21. Joppa MA, Gogas KR, Foster AC & Markison S 2007 Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice. Peptides 28 636-642.
22. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H & Wakabayashi I 2000 Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 141 4797-4800.
23. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB & Vasan RS 2002 Obesity and the risk of heart failure. New England Journal of Medicine 347 305-313.
24. Levine B, Kalman J, Mayer L, FillitHM& PackerM1990 Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New England Journal of Medicine 323 236-241.
25. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB,Murabito JM, Vasan RS, Benjamin EJ & Levy D 2002 Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106 3068-3072. (Pubitemid 35440290) (Pubitemid 35440290)
26. Marks DL, Ling N & Cone RD 2001 Role of the central melanocortin system in cachexia. Cancer Research 61 1432-1438. (Pubitemid 34292569)
27. Mioni C, Giuliani D, Cainazzo MM, Leone S, Bazzani C, Grieco P, Novellino E, Tomasi A, Bertolini A & Guarini S 2003 Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors. European Journal of Pharmacology 477 227-234.
28. Mountjoy KG, Jenny Wu CS, Dumont LM &Wild JM 2003 Melanocortin-4 receptor messenger ribonucleic acid expression in rat cardiorespiratory, musculoskeletal, and integumentary systems. Endocrinology 144 5488-5496.
29. Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, Shimizu W, Hosoda H, Hirota Y, Ishida H, Mori H et al. 2001 Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104 1430-1435.
30. Nahrendorf M, Hiller KH, Hu K, Ertl G, Haase A & BauerWR2003 Cardiac magnetic resonance imaging in small animal models of human heart failure. Medical Image Analysis 7 369-375.
31. Ogimoto K, Harris MK Jr & Wisse BE 2006 MyD88 is a key mediator of anorexia, but not weight loss, induced by lipopolysaccharide and interleukin-1 beta. Endocrinology 147 4445-4453.
32. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I & Barsh GS 1997 Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278 135-138.
33. Plata-Salaman CR 2001 Cytokines and feeding. International Journal of Obesity and Related Metabolic Disorders 25 (Suppl 5) S48-S52.
34. Plata-Salaman CR, Sonti G, Borkoski JP, Wilson CD & French-Mullen JMB 1996 Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiology and Behavior 60 867-875.
35. Reyes TM & Sawchenko PE 2002 Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia. Journal of Neuroscience 22 5091-5099.
36. RosamondW, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B et al. 2008 Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 e25-e146.
37. Scarlett JM, Jobst EE, Enriori PJ, Bowe DD, Batra AK, Grant WF, Cowley MA & Marks DL 2007 Regulation of central melanocortin signaling by interleukin-1b. Endocrinology 148 4217-4225.
38. Scarlett JM, Zhu X, Enriori PJ, Bowe DD, Batra AK, Levasseur PR, Grant WF, Meguid MM, Cowley MA & Marks DL 2008 Regulation of agouti-related protein messenger ribonucleic acid transcription and peptide secretion by acute and chronic inflammation. Endocrinology 149 4837-4845.
39. Schulze PC, Gielen S, Adams V, Linke A, Mobius-Winkler S, Erbs S, Kratzsch J, Hambrecht R & Schuler G 2003 Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulinlike growth factor-I in chronic heart failure. Basic Research in Cardiology 98 267-274.
40. Shioura KM, Geenen DL & Goldspink PH 2007 Assessment of cardiac function with the pressure-volume conductance system following myocardial infarction in mice. American Journal of Physiology. Heart and Circulatory Physiology 293 H2870-H2877.
41. Shioura KM, Geenen DL & Goldspink PH 2008 Sex-related changes in cardiac function following myocardial infarction in mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 295 R528-R534.
42. Small CJ, Kim MS, Stanley SA, Mitchell JR, Murphy K, Morgan DG, Ghatei MA & Bloom SR 2001 Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. Diabetes 50 248-254.
43. Tinsley FC, Taicher GZ & Heiman ML 2004 Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. Obesity Research 12 150-160. (Pubitemid 41137499)
44. Tisdale MJ 1997 Biology of cachexia. Journal of the National Cancer Institute 89 1763-1773.
45. Wisse BE, Ogimoto K, Tang J, Harris MK Jr, Raines EW & Schwartz MW 2007 Evidence that lipopolysaccharide-induced anorexia depends upon central, rather than peripheral, inflammatory signals. Endocrinology 148 5230-5237.